| Study period | ||||||
---|---|---|---|---|---|---|---|
Screening | Randomisation | Post-randomisation | Post-randomisation follow-up | ||||
TIMEPOINT | Pre-T0 | Pre-T0 | T0 | T0-T1 | T1 +14 weeks | T2 +26 weeks | Â |
ENROLMENT: | |||||||
 Eligibility screen | X |  |  |  |  |  |  |
 Referral to research team | X |  |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |  |
 Randomisation |  | X |  |  |  |  |  |
 INTERVENTIONS |  |  |  | X |  |  |  |
ASSESSMENTS: | |||||||
 CDI-2 | X |  | X |  | X | X |  |
 Demographic information | X |  |  |  |  |  |  |
 DAWBA (includes SDQ) CYP completed | X |  |  |  |  |  |  |
 DAWBA (includes SDQ) Carer completed | X |  |  |  |  |  |  |
 PAR-Q | X |  |  |  |  |  |  |
 PANAS |  |  | X |  | X | X |  |
 Self-efficacy scale |  |  | X |  | X | X |  |
 Social Support Scale |  |  | X |  | X | X |  |
 Caregiver burden |  |  | X |  | X | X |  |
 Adherence |  |  |  | X |  |  |  |
 Peak and average HR |  |  |  | X |  |  |  |
 Ratings of Perceived  Exertion |  |  |  | X |  |  |  |
 Measured physical activity |  |  | X |  | X | X |  |
 Y-PAQ |  |  | X |  | X | X |  |
 COM-B measures |  |  | X |  | X | X |  |
 EQ-5D-5L |  |  | X |  | X | X |  |
 CSRI |  |  | X |  | X | X |  |
 CHU-9D |  |  | X |  | X | X |  |
 Focus groups |  |  |  |  |  |  | X |
ADVERSE EVENT MONITORING | Â | Â | X | X | X | X | X |